RxDoctor Payments Data

Ravi Gada

Reproductive Endocrinology · Dallas, TXNPI 1063527588

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.9%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Ferring Pharmaceuticals Inc. accounts for 66.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $6,940 and has fallen 94.2% since, to $400 in 2025.

$9,678in general payments, 2019–2025

Across 161 payments — averaging $60.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ferring Pharmaceuticals Inc.$6K
  • Coopersurgical, Inc.$1K
  • Organon$742
  • EMD Serono, Inc.$622
  • AbbVie$197
  • Covidien LP$151
  • plus $245 from 7 others

What the payments were for

  • Consulting fees$5,02652%
  • Travel & lodging$7898%
  • Food & beverage$3,85740%
  • Education$70%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,678 in reported general payments places this provider in the 85th percentile of 142 reproductive endocrinology providers in Texas.

See all reproductive endocrinology providers in Texas

Other reproductive endocrinology in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →